CRH Medical (NYSEAMERICAN:CRHM) Lowered to “C+” at TheStreet

TheStreet lowered shares of CRH Medical (NYSEAMERICAN:CRHM) from a b- rating to a c+ rating in a research report released on Friday, March 29th, TheStreetRatingsTable reports.

A number of other research analysts have also commented on the stock. TD Securities reaffirmed a buy rating on shares of CRH Medical in a research report on Tuesday, January 8th. Clarus Securities reiterated a buy rating on shares of CRH Medical in a research note on Wednesday, March 20th. Finally, Zacks Investment Research upgraded shares of CRH Medical from a sell rating to a hold rating in a research report on Thursday, January 3rd.

NYSEAMERICAN:CRHM traded up $0.02 during trading hours on Friday, reaching $2.89. The company’s stock had a trading volume of 30,000 shares, compared to its average volume of 75,315. CRH Medical has a one year low of $2.51 and a one year high of $4.50.

CRH Medical (NYSEAMERICAN:CRHM) last released its quarterly earnings results on Wednesday, March 13th. The company reported $0.02 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.02. The firm had revenue of $32.02 million for the quarter, compared to the consensus estimate of $31.40 million.

Several hedge funds have recently modified their holdings of the company. Mackenzie Financial Corp acquired a new stake in shares of CRH Medical during the 4th quarter worth approximately $1,413,000. Morgan Stanley lifted its stake in CRH Medical by 116.7% in the 3rd quarter. Morgan Stanley now owns 3,653,460 shares of the company’s stock valued at $14,432,000 after purchasing an additional 1,967,537 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in CRH Medical by 38.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,486,400 shares of the company’s stock valued at $5,871,000 after purchasing an additional 409,100 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its stake in CRH Medical by 21.7% in the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 2,201,799 shares of the company’s stock valued at $6,739,000 after purchasing an additional 392,900 shares during the last quarter. Finally, Acadian Asset Management LLC lifted its stake in CRH Medical by 163.9% in the 4th quarter. Acadian Asset Management LLC now owns 234,320 shares of the company’s stock valued at $716,000 after purchasing an additional 145,520 shares during the last quarter.

About CRH Medical

CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures.

See Also: Different Options Trading Strategies

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.